Boult Wade Tennant
People » Dr Jasmine Wyatt

Dr Jasmine Wyatt

Patent Assistant

London

Contact
v-card Download V-card
Address
Memberships
  • CIPA
Qualifications
  • Certificate in Intellectual Property Law, Queen Mary University of London
  • PhD Biochemistry and Molecular Biology, King’s College London
  • Master of Research (MRes) Translational Cancer Medicine, King’s College London
  • BSc Biochemistry, King’s College London

I joined Boult following my PhD and time as a Post-Doctoral Researcher at King’s College London.

I have a strong technical background in a range of areas across biochemistry and cell biology. My love for science and keen interest in business and law led me to this profession.

I have a particular interest in oncology, having specialised for a number of years in cancer research during my academic career. I completed a doctorate investigating tumour-selective proteins with a focus on protein-engineering. I continued my research work as a post-doctoral scientist exploring the contribution of kinases in the metastasis of pancreatic cancer using CRISPR-Cas9.

Above all, I really enjoy learning about new technologies, keeping up-to-date with scientific discoveries and interacting with major innovators in the biotechnology space.

Recent experience
Relevant Search Terms
Recommended Sites
Suggested Media
Recognitions
Additional Info
Languages
“I have a strong technical background in a range of areas across biochemistry and cell biology and have a particular interest in oncology, having specialised for a number of years in cancer research during my academic career.”
Sector Experience
Biotechnology
  • Drug delivery
  • Gene editing (e.g. CRISPR)
  • Genomic and molecular tools and methods
  • Recombinant protein production and purification
Pharmaceuticals
  • Small molecule pharmaceuticals

I joined Boult following my PhD and time as a Post-Doctoral Researcher at King’s College London.

I have a strong technical background in a range of areas across biochemistry and cell biology. My love for science and keen interest in business and law led me to this profession.

I have a particular interest in oncology, having specialised for a number of years in cancer research during my academic career. I completed a doctorate investigating tumour-selective proteins with a focus on protein-engineering. I continued my research work as a post-doctoral scientist exploring the contribution of kinases in the metastasis of pancreatic cancer using CRISPR-Cas9.

Above all, I really enjoy learning about new technologies, keeping up-to-date with scientific discoveries and interacting with major innovators in the biotechnology space.

Recent experience
Relevant Search Terms
Recommended Sites
Suggested Media
Recognitions
Additional Info

Insights

G1/24 explained: the description and figures must be considered in claim interpretation

G1/24 clarifies claim interpretation under the EPC, confirming that the description and drawings must always be consulted - an important shift in EPO practice.

G1/24: The Enlarged Board of Appeal issues its decision

In G1/24, the EPO Enlarged Board ruled that claims must always be interpreted in light of the description and drawings when assessing patentability, even if the claims appear clear on their own.

Update: Oral proceedings in case G1/24 – we await the Enlarged Board’s written decision

Oral proceedings before the Enlarged Board of Appeal (G1/24) were held on 28 March 2025, to discuss the extent to which the

Multidrug-resistant bacteria discovered in space

Microbes are ubiquitous here on Earth and can survive a range of environmental conditions encompassing broad ranges of temperature, pH, salinity, energy,

Clinical trials and prior disclosure – a difficult balancing act for patentees.

The European Patent Office (EPO) has recently ruled that patients in a clinical trial were not members of the public such that

INSIGHTS